Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.069 AUD | +1.47% |
|
-1.43% | -27.37% |
Jul. 03 | Island Pharmaceuticals Acquiring Clinical-Stage Antiviral Molecule | MT |
May. 08 | Island Pharmaceuticals Reallocates Grant Funding to Dengue Fever Trial; Shares Rally 13% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-27.37% | 5.8M | |
+20.17% | 126B | |
+24.67% | 118B | |
+23.58% | 27.87B | |
-17.74% | 20.95B | |
-15.92% | 16.92B | |
-15.21% | 16.18B | |
+11.91% | 14.84B | |
-47.10% | 14.79B | |
+54.50% | 14.08B |
- Stock Market
- Equities
- ILA Stock
- News Island Pharmaceuticals Limited
- Island Pharmaceuticals Submits IND Application to US FDA for Clinical Trial of Dengue Fever Drug Candidate